EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access · CC BY 4.0

Synbiotic HQP08 Supplementation for Hair Loss and Depressive Symptoms: An Open-Label Pilot Study of Clinical Outcomes and Gut Microbiome Changes

Zhilu Xu iD, Raphaela I Lau, Haoyu Qi, Martin C S Wong iD, Kingsley H N Chan, Ivan S F Lau iD, Jessica Y L Ching, Pui Kuan Cheong, Francis K L Chan iD, Siew C Ng

Nutrients · 2026

DOI: 10.3390/nu18193111 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Nutrients, 2026. Verfasst von Zhilu Xu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Microbiota I-Center (MagIC), Hong Kong SAR, China. Hauptthemen laut MEDLINE: Alopecia, Gastrointestinal Microbiome, Synbiotics, Depression. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: InnoHK, InnoHK initiative of the Innovation and Technology Commission of the Hong Kong Special Administrative Region Government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gut microbiota dysregulation has been implicated in hair loss via the gut–skin axis, but human interventional data are limited. We previously showed that Bifidobacterium longum HK003 reverses alopecia-like phenotypes in mice.

Methods

We conducted an open-label, single-arm pilot study to evaluate an HK003-containing synbiotic (HQP08) in 32 adults with self-reported hair loss over 8 weeks. The primary endpoint was the proportion of participants reporting improvement on the Patient Global Impression of Change (PGI-C) scale at week 8. Secondary outcomes included changes in hair loss severity, 60 s hair count, depressive symptoms (PHQ-9), safety, and gut microbiome composition (Chinese Clinical Trial Registry ChiCTR2500112698).

Results

At week 8, 62.5% (20/32) of participants reported PGI-C improvement. Significant reductions were observed in hair loss severity (p = 0.0008), 60 s hair count (p = 0.0048), and PHQ-9 scores (p = 0.002). Younger age was associated with PGI-C response (OR per year 0.86, 95% CI: 0.73–0.98, p = 0.037). Metagenomic analysis identified engraftment of B. longum HK003-like profiles in a subset of participants at week 12. Changes in microbial pathways related to thiamine metabolism, vitamin B12 salvage, and lipopolysaccharide biosynthesis were associated with ΔPHQ-9 (FDR-adjusted p < 0.05), but not with hair-related endpoints. No serious adverse events occurred.

Conclusions

This first-in-human pilot study suggests that HQP08 was well tolerated and was associated with within-participant changes in hair-loss measurements and PHQ-9 scores. Randomized controlled trials are warranted to confirm efficacy and further elucidate mechanisms within the gut–brain–skin axis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlopeciaGastrointestinal MicrobiomeSynbioticsDepressionBifidobacterium longumHumansPilot ProjectsFemaleMaleAdultMiddle AgedTreatment OutcomeDietary SupplementsYoung Adult

Stichwörter der Autor:innen

alopeciagut microbiomegut–skin axishair losssynbiotic

Autor:innen und Institutionen

  • Microbiota I-Center (MagIC), Hong Kong SAR, China.
  • Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Institute of Digestive Disease, State Key Laboratory of Digestive Diseases, Li Ka Shing Institute of Health Science, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Jockey Club School of Public Health and Primary Care, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.
  • Dermamier Skin and Laser Center, Hong Kong SAR, China.
  • Center for Gut Microbiota Research, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.

ORCID-Profile: Zhilu Xu, Martin C S Wong, Ivan S F Lau, Francis K L Chan

Förderung

  • InnoHK
  • InnoHK initiative of the Innovation and Technology Commission of the Hong Kong Special Administrative Region Government

Zitieren

APA

Xu, Z., Lau, R. I., Qi, H., Wong, M. C. S., Chan, K. H. N., Lau, I. S. F., Ching, J. Y. L., Cheong, P. K., Chan, F. K. L., & Ng, S. C. (2026). Synbiotic HQP08 Supplementation for Hair Loss and Depressive Symptoms: An Open-Label Pilot Study of Clinical Outcomes and Gut Microbiome Changes. Nutrients. https://doi.org/10.3390/nu18193111

Vancouver

Xu Z, Lau RI, Qi H, Wong MCS, Chan KHN, Lau ISF, et al. Synbiotic HQP08 Supplementation for Hair Loss and Depressive Symptoms: An Open-Label Pilot Study of Clinical Outcomes and Gut Microbiome Changes. Nutrients. 2026. doi:10.3390/nu18193111

BibTeX
@article{Xu2026,
  author = {Xu, Zhilu and Lau, Raphaela I and Qi, Haoyu and Wong, Martin C S and Chan, Kingsley H N and Lau, Ivan S F and Ching, Jessica Y L and Cheong, Pui Kuan and Chan, Francis K L and Ng, Siew C},
  title = {Synbiotic HQP08 Supplementation for Hair Loss and Depressive Symptoms: An Open-Label Pilot Study of Clinical Outcomes and Gut Microbiome Changes},
  journal = {Nutrients},
  year = {2026},
  doi = {10.3390/nu18193111}
}
Kostenlos starten →